Reduced Interleukin-17 and Transforming Growth Factor Beta Levels in Peripheral Blood as Indicators for Following the Course of Bladder Cancer |
Baharlou, Rasoul
(Department of Immunology and Microbiology, School of Medicine, Jahrom University of Medical Sciences)
Vasmehjani, Abbas Ahmadi (Department of Immunology and Microbiology, School of Medicine, Jahrom University of Medical Sciences) Dehghani, Ali (Department of Nursing, School of Nursing, Jahrom University of Medical Sciences) Ghobadifar, Mohamed Amin (Department of Student Research Committee, School of Medicine, Jahrom University of Medical Sciences) Khoubyari, Mahshid (Department of Student Research Committee, School of Medicine, Jahrom University of Medical Sciences) |
1 | Zhang, B., G. Rong, H. Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G. Wei, X. Liu, and G. Fang. 2008. The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374: 533-537. DOI |
2 | Zhu, X., L. A. Mulcahy, R. A. Mohammed, A. H. Lee, H. A. Franks, L. Kilpatrick, A. Yilmazer, E. C. Paish, I. O. Ellis, P. M. Patel, and A. M. Jackson. 2008. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res. 10: R95. DOI |
3 | Kato, T., H. Furumoto, T. Ogura, Y. Onishi, M. Irahara, S. Yamano, M. Kamada, and T. Aono. 2001. Expression of IL-17 mRNA in ovarian cancer. Biochem. Biophys. Res. Commun. 282: 735-738. DOI ScienceOn |
4 | Chi, L. J., H. T. Lu, G. L. Li, X. M. Wang, Y. Su, W. H. Xu, and B. Z. Shen. 2010. Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin. Exp. Immunol. 161: 480-489. DOI |
5 | Lee, J. J., Y. L. Chang, W. L. Lai, J. Y. Ko, M. Y. Kuo, C. P. Chiang, M. Azuma, C. W. Chen, and J. S. Chia. 2011. Increased prevalence of interleukin-17-producing tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck 33: 1301-1308. DOI |
6 | Kwon, K. A., S. H. Kim, S. Y. Oh, S. Lee, J. Y. Han, K. H. Kim, R. Y. Goh, H. J. Choi, K. J. Park, M. S. Roh, H. J. Kim, H. C. Kwon, and J. H. Lee. 2010. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 10: 203. DOI |
7 | Ravishankaran, P. and R. Karunanithi. 2011. Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients. World J. Surg. Oncol. 9: 18. DOI ScienceOn |
8 | Jeon, S. H., B. C. Chae, H. A. Kim, G. Y. Seo, D. W. Seo, G. T. Chun, N. S. Kim, S. W. Yie, W. H. Byeon, S. H. Eom, K. S. Ha, Y. M. Kim, and P. H. Kim. 2007. Mechanisms underlying TGF--induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J. Leukoc. Biol. 81: 557-566. DOI ScienceOn |
9 | Wang, L., T. Yi, M. Kortylewski, D. M. Pardoll, D. Zeng, and H. Yu. 2009. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J. Exp. Med. 206: 1457-1464. DOI ScienceOn |
10 | Radosavljevic, G., B. Ljujic, I. Jovanovic, Z. Srzentic, S. Pavlovic, N. Zdravkovic, M. Milovanovic, D. Bankovic, M. Knezevic, L. J. Acimovic, and N. Arsenijevic. 2010. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma. Neoplasma 57: 135-144. DOI |
11 | Jovanovic, D. V., J. A. Di Battista, J. Martel-Pelletier, F. C. Jolicoeur, Y. He, M. Zhang, F. Mineau, and J. P. Pelletier. 1998. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J. Immunol. 160: 3513-3521. |
12 | Nam, J. S., M. Terabe, M. J. Kang, H. Chae, N. Voong, Y. A. Yang, A. Laurence, A. Michalowska, M. Mamura, S. Lonning, J. A. Berzofsky, and L. M. Wakefield. 2008. Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res. 68: 3915-3923. DOI ScienceOn |
13 | Muranski, P., A. Boni, P. A. Antony, L. Cassard, K. R. Irvine, A. Kaiser, C. M. Paulos, D. C. Palmer, C. E. Touloukian, K. Ptak, L. Gattinoni, C. Wrzesinski, C. S. Hinrichs, K. W. Kerstann, L. Feigenbaum, C. C. Chan, and N. P. Restifo. 2008. Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 112: 362-373. DOI |
14 | Ankathatti Munegowda M, Deng Y, Mulligan SJ, and Xiang J. 2011. Th17 and Th17-stimulated CD8+ T cells play a distinct role in Th17-induced preventive and therapeutic antitumor immunity. Cancer Immunol. Immunother. 60: 1473-1484. DOI |
15 | Kolahdoozan S, Sadjadi A, Radmard AR, and Khademi H. 2010. Five common cancers in Iran. Arch. Iran. Med. 13: 143-146. |
16 | Passos, S. T., J. S. Silver, A. C. O'Hara, D. Sehy, J. S. Stumhofer, and C. A. Hunter. 2010. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J. Immunol. 184: 1776-1783. DOI |
17 | Mucida, D. and H. Cheroutre. 2007. TGFbeta and retinoic acid intersect in immune-regulation. Cell Adh. Migr. 1: 142-144. DOI |
18 | Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057. DOI ScienceOn |
19 | Fossiez, F., O. Djossou, P. Chomarat, L. Flores-Romo, S. Ait-Yahia, C. Maat, J. J. Pin, P. Garrone, E. Garcia, S. Saeland, D. Blanchard, C. Gaillard, B. Das Mahapatra, E. Rouvier, P. Golstein, J. Banchereau, and S. Lebecque. 1996. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183: 2593-2603. DOI ScienceOn |
20 | Murugaiyan, G. and B. Saha. 2009. Protumor vs antitumor functions of IL-17. J. Immunol. 183: 4169-4175. DOI |
21 | Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Fili, S. Ferri, F. Frosali, F. Giudici, P. Romagnani, P. Parronchi, F. Tonelli, E. Maggi, and S. Romagnani. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861. DOI ScienceOn |
22 | Honorati, M. C., S. Neri, L. Cattini, and A. Facchini. 2006. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts1. Osteoarthritis Cartilage 14: 345-352. DOI |
23 | Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 2005. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 175: 5-14. |
24 | Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141. DOI ScienceOn |
25 | Peck, A. and E. D. Mellins. 2009. Breaking old paradigms: Th17 cells in autoimmune arthritis. Clin. Immunol. 132: 295-304. DOI ScienceOn |
26 | Sfanos, K. S., T. C. Bruno, C. H. Maris, L. Xu, C. J. Thoburn, A. M. DeMarzo, A. K. Meeker, W. B. Isaacs, and C. G. Drake. 2008. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin. Cancer Res. 14: 3254-3261. DOI |
27 | Kryczek, I., S. Wei, L. Zou, S. Altuwaijri, W. Szeliga, J. Kolls, A. Chang, and W. Zou. 2007. Cutting edge: Th17 and regulatory T cell dynamics and the regulation by IL-2 in the tumor microenvironment. J. Immunol. 178: 6730-6733. DOI |
28 | Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348. DOI ScienceOn |
29 | Chen, M. F., P. Y. Lin, C. F. Wu, W. C. Chen, and C. T. Wu. 2013. IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer. PLoS One 8: e61901. DOI |
30 | Yang, L., Y. Qi, J. Hu, L. Tang, S. Zhao, and B. Shan. 2012. Expression of Th17 cells in breast cancer tissue and its association with clinical parameters. Cell Biochem. Biophys. 62: 153-159. DOI ScienceOn |
31 | Weaver, C. T. and R. D. Hatton. 2009. Interplay between the TH17 and TReg cell lineages: a (co-) evolutionary perspective. Nat. Rev. Immunol. 9: 883-889. DOI ScienceOn |
32 | Khatami, M. 2009. Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity: a common denominator mapping chronic diseases. Cell Biochem. Biophys. 55: 55-79. DOI ScienceOn |
33 | Erdman, S. E. and T. Poutahidis. 2010. Roles for inflammation and regulatory T cells in colon cancer. Toxicol. Pathol. 38: 76-87. DOI ScienceOn |
34 | Connolly, E. C., J. Freimuth, and R. J. Akhurst. 2012. Complexities of TGF-beta Targeted Cancer Therapy. Int. J. Biol. Sci. 8: 964-978. DOI |
35 | Zhang, B., G. Rong, H. Wei, M. Zhang, J. Bi, L. Ma, X. Xue, G. Wei, X. Liu, G. and Fang. 2008. The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374: 533-537. DOI |
36 | Zhang, J. P., J. Yan, J. Xu, X. H. Pang, M. S. Chen, L. Li, C. Wu, S. P. Li, and L. Zheng. 2009. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50: 980-989. DOI |
37 | Shime, H., M. Yabu, T. Akazawa, K. Kodama, M. Matsumoto, T. Seya, and N. Inoue. 2008. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J. Immunol. 180: 7175-7183. DOI |